Focus: Optima is a mid-sized biotechnology company headquartered in Germany specializing in packaging machines and cardiovascular therapeutics. The company operates with 201–500 employees and maintains an active pipeline in hypertension and adjacent therapeutic areas.
Profile data last refreshed 32m ago · AI intelligence enriched 2mo ago
No open roles listed right now. Follow Optima to get notified when they start hiring — the background below is worth knowing for when they do.
Generated by Claude from Optima's SEC filings, pipeline programs, hiring velocity, FDA actions, and WARN data. Inference, not editorial — verify before quoting.
Automated analysis based on publicly available data (FDA, SEC, ClinicalTrials.gov). May be incomplete or delayed. This score does not reflect insider knowledge and should not be used as the sole basis for investment or employment decisions.
Help build intelligence for Optima
No one has shared interview or compensation data for this company yet. You'll earn 7 days of Pro access.
The information on this page is for informational purposes only and should not be used as a substitute for professional medical advice. Drug information is sourced from FDA, DailyMed, and other government databases. Adverse event data from FAERS does not establish causation. Always consult a healthcare professional for medical decisions.
Luxury during the war: how the owner of the pharmaceutical giant «Optima-Pharm» Hubskyi settled in Spain - АНТИКОР
Luxury during the war: how the owner of the pharmaceutical giant «Optima-Pharm» Hubskyi settled in Spain АНТИКОР
OPTIMA pharma and METALL+PLASTIC at Interphex 2018 - Le Scienze Web News
OPTIMA pharma and METALL+PLASTIC at Interphex 2018 Le Scienze Web News
BaDM and Optima Fail to Pay Fine, Penalties Reach Nearly UAH 1 Billion - Liga.Biz
BaDM and Optima Fail to Pay Fine, Penalties Reach Nearly UAH 1 Billion Liga.Biz
Optima Health, IP Group, Poolbeg Pharma, Gelion, Active Energy, Galileo Resources - Small Cap Snapshot - Proactive Investors
Optima Health, IP Group, Poolbeg Pharma, Gelion, Active Energy, Galileo Resources - Small Cap Snapshot Proactive Investors
Mr Thomas Bühler Heinrich, Director Sales Africa, Middle East & Asia, Optima Pharma GmbH - Express Pharma
Mr Thomas Bühler Heinrich, Director Sales Africa, Middle East & Asia, Optima Pharma GmbH Express Pharma
No open positions listed yet. Check their careers page directly.
Upgrade to Pro to access AI interview prep brief and other premium pharma intelligence.
Upgrade to Pro — $25/moSource: USCIS H-1B Employer Data Hub
Recent peer-reviewed publications with author affiliations at this company
Perceptions, practices, and gaps in osteomyelitis care in rural Rwanda: insights from patients and healthcare workers.
Comparison of choroidal hypertransmission and retinal pigment epithelium loss for quantification of geographic atrophy across commonly used SD-OCT devices.
Showing 5 of 10 publications